Activaero appoints chief business officer
Christian Pangratz takes the role
Pangratz joins Activaero from Nektar Therapeutics, in San Francisco, US, where he recently served as executive director of business development. He brings to Activaero 20 years of life science experience.
Pangratz will join the Activaero management team and lead all business development, marketing and alliance management activities. He replaces Henrik Luessen, who has decided to focus on his own consultancy firm, but will continue to support Activaero’s business development team on a part-time basis.
You may also like
Research & Development
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines
Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals
Cell & Gene Therapy
Vitalant adds NGS testing to Pittsburgh lab as part of national cell and gene therapy strategy
The expansion connects Phoenix, San Francisco and Pittsburgh laboratories into a hub-and-spoke model, strengthening analytical support for CGT development, transfusion medicine and inherited bleeding disorder diagnostics
Marketing
CPHI Milan introduces new specialist AI, cold chain, contamination control and labelling zones at this year's event
CPHI Milan 2026, one of the pharmaceutical industry's largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the future of healthcare manufacturing and supply chains
Analysis
AP Connect 4.0 strengthens data management and traceability in connected laboratories
Anton Paar has announced the latest update of its lab execution system, AP Connect 4.0, featuring enhanced capabilities for centralised user management, secure data handling, and improved traceability across laboratory workflows